BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27143302)

  • 1. Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice.
    Bergstrom K; Fu J; Johansson ME; Liu X; Gao N; Wu Q; Song J; McDaniel JM; McGee S; Chen W; Braun J; Hansson GC; Xia L
    Mucosal Immunol; 2017 Jan; 10(1):91-103. PubMed ID: 27143302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice.
    Bergstrom K; Liu X; Zhao Y; Gao N; Wu Q; Song K; Cui Y; Li Y; McDaniel JM; McGee S; Chen W; Huycke MM; Houchen CW; Zenewicz LA; West CM; Chen H; Braun J; Fu J; Xia L
    Gastroenterology; 2016 Jul; 151(1):152-164.e11. PubMed ID: 27059389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of intestinal O-glycans promotes spontaneous duodenal tumors.
    Gao N; Bergstrom K; Fu J; Xie B; Chen W; Xia L
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G74-83. PubMed ID: 27229122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core 3-derived O-glycans are essential for intestinal mucus barrier function.
    Xia L
    Methods Enzymol; 2010; 479():123-41. PubMed ID: 20816163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans.
    An G; Wei B; Xia B; McDaniel JM; Ju T; Cummings RD; Braun J; Xia L
    J Exp Med; 2007 Jun; 204(6):1417-29. PubMed ID: 17517967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice.
    Fu J; Wei B; Wen T; Johansson ME; Liu X; Bradford E; Thomsson KA; McGee S; Mansour L; Tong M; McDaniel JM; Sferra TJ; Turner JR; Chen H; Hansson GC; Braun J; Xia L
    J Clin Invest; 2011 Apr; 121(4):1657-66. PubMed ID: 21383503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2.
    Thomsson KA; Holmén-Larsson JM; Angström J; Johansson ME; Xia L; Hansson GC
    Glycobiology; 2012 Aug; 22(8):1128-39. PubMed ID: 22581805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Related Mucus Barrier Dysfunction in Mice Is Related to the Changes in Muc2 Mucin in the Colon.
    Sang X; Wang Q; Ning Y; Wang H; Zhang R; Li Y; Fang B; Lv C; Zhang Y; Wang X; Ren F
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture.
    Sommer F; Adam N; Johansson ME; Xia L; Hansson GC; Bäckhed F
    PLoS One; 2014; 9(1):e85254. PubMed ID: 24416370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muc2 mucin O-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway.
    Wei J; Chen C; Feng J; Zhou S; Feng X; Yang Z; Lu H; Tao H; Li L; Xv H; Xuan J; Wang F
    J Transl Med; 2023 Nov; 21(1):793. PubMed ID: 37940996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.
    Holmén Larsson JM; Thomsson KA; Rodríguez-Piñeiro AM; Karlsson H; Hansson GC
    Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(5):G357-63. PubMed ID: 23832516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis.
    Zarepour M; Bhullar K; Montero M; Ma C; Huang T; Velcich A; Xia L; Vallance BA
    Infect Immun; 2013 Oct; 81(10):3672-83. PubMed ID: 23876803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated miR-124-3p in the aging colon disrupts mucus barrier and increases susceptibility to colitis by targeting T-synthase.
    Huang L; Sun TY; Hu LJ; Hu SL; Sun HM; Zhao FQ; Wu B; Yang S; Ji FQ; Zhou DS
    Aging Cell; 2020 Nov; 19(11):e13252. PubMed ID: 33040455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.
    Johansson ME; Gustafsson JK; Holmén-Larsson J; Jabbar KS; Xia L; Xu H; Ghishan FK; Carvalho FA; Gewirtz AT; Sjövall H; Hansson GC
    Gut; 2014 Feb; 63(2):281-91. PubMed ID: 23426893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin-type O-glycans and their roles in intestinal homeostasis.
    Bergstrom KS; Xia L
    Glycobiology; 2013 Sep; 23(9):1026-37. PubMed ID: 23752712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency.
    Jacobs JP; Lin L; Goudarzi M; Ruegger P; McGovern DP; Fornace AJ; Borneman J; Xia L; Braun J
    Gut Microbes; 2017 Jan; 8(1):1-16. PubMed ID: 27874308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of mucin-type
    Song K; Fu J; Song J; Herzog BH; Bergstrom K; Kondo Y; McDaniel JM; McGee S; Silasi-Mansat R; Lupu F; Chen H; Bagavant H; Xia L
    J Biol Chem; 2017 Oct; 292(40):16491-16497. PubMed ID: 28842487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-22 promotes mucin-type O-glycosylation and MATH1
    Singh A; Beaupre M; Villegas-Novoa C; Shiomitsu K; Gaudino SJ; Tawch S; Damle R; Kempen C; Choudhury B; McAleer JP; Sheridan BS; Denoya P; Blumberg RS; Hearing P; Allbritton NL; Kumar P
    Cell Rep; 2024 May; 43(5):114206. PubMed ID: 38733584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the gel-forming MUC2 mucin and its O-glycosylation in the protection against colitis and colorectal cancer.
    Kawashima H
    Biol Pharm Bull; 2012; 35(10):1637-41. PubMed ID: 23037153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Loss of Core 1-Derived
    Suzuki R; Nakamura Y; Koiwai R; Fuseya S; Murakami Y; Hagiwara K; Sato T; Takahashi S; Kudo T
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.